Goldline Pharmaceutical Ltd IPO
Price Range
₹41 - ₹43
-
Min. Quantity
6,000 Shares
Closes on
May 14, 2026
-
Min. investment
₹2,58,000
Goldline Pharmaceutical Ltd IPO Timeline
| Event | Date |
|---|---|
| Goldline Pharmaceutical Ltd IPO Opening Date | May 12, 2026 |
| Goldline Pharmaceutical Ltd IPO Closing Date | May 14, 2026 |
| Basis of Allotment | May 15, 2026 |
| Initiation of Refunds | May 18, 2026 |
| Credit of Shares to Demat | May 18, 2026 |
| Goldline Pharmaceutical Ltd IPO Listing Date | May 19, 2026 |
Goldline Pharmaceutical Ltd IPO Details
| Goldline Pharmaceutical Ltd IPO Date | May 12, 2026 to May 14, 2026 |
| Goldline Pharmaceutical Ltd IPO Face Value | ₹10 per share |
| Goldline Pharmaceutical Ltd IPO Price | ₹41 to ₹43 per share |
| Goldline Pharmaceutical Ltd IPO Lot Size | 6,000 |
| Issue Size | Shares of ₹10 (aggregating up to ₹11.61 Cr) |
| Fresh Issue | Shares of ₹10 (aggregating up to ₹11.61 Cr) |
| Offer for Sale | - |
| Issue Type | Book Building - SME |
| Listing At | BSE - SME |
| QIB Shares Offered | Not more than 5,40,000 of the Net Offer |
| Retail Shares Offered | Not less than 9,00,000 of the Net Offer |
| NII (HNI) Shares Offered | Not less than 5,28,000 of the Net Offer |
| Company Promoters | Amol Laxmikant Mujumdar, Swapan Premprakash Khandelwal, Asha Swapan Khandelwal |
Goldline Pharmaceutical Ltd IPO Lot Size
The Goldline Pharmaceutical Ltd IPO lot size is 6,000 shares. A retail-individual investor can apply for up to 0 lots (0 shares or ₹0).
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Minimum | 1 | 6,000 | ₹2,58,000 |
| Maximum | - | 0 | ₹0 |
- Strengths
- Risks
- Opportunities
- Experienced promoters and management team with industry knowledge and a track record.
- Asset-light business model and competitive products.
- Scalable Business Model.
- Wide and diverse range of product offerings.
- Strong Supplier and Vendor Relationships.
- Established Distribution Network.
Company Financials
Goldline Pharmaceutical Ltd Financial Information (Restated)
| Period Ended | Total Assets | Total Revenue | Profit After Tax |
|---|---|---|---|
| 03-2025 | 26.28 | 28.06 | 2.83 |
| 03-2024 | 22.93 | 23.57 | 1.81 |
| 03-2023 | 19.39 | 19.85 | 0.26 |
| Amount in ₹ Crore | |||
Objects of the Issue
The company proposes to utilise the Net Proceeds from the Fresh Issue towards funding the following objects:
- Repayment of all or a portion of certain outstanding borrowings availed by its company
- General Corporate Purpose
Goldline Pharmaceutical Ltd IPO Promoter Holding
| Pre Issue Share Holding | 39.85% |
| Post Issue Share Holding | 28.65% |
Goldline Pharmaceutical Ltd IPO Subscription Status (Bidding Detail)
The Goldline Pharmaceutical Ltd IPO is subscribed 781.85 times on May 14, 2026 05:00:00 PM. The public issue subscribed 881.1533 times in the retail category, 180.2167 times in the QIB category, and 1227.9034 times in the NII category. Check Day by Day Subscription Details (Live Status)
| Category | QIB | NII | Retail | Employee | Total |
| Subscription (times) | 180.2167 | 1227.9034 | 881.1533 | - | 781.85 |
Goldline Pharmaceutical Ltd IPO Prospectus
Goldline Pharmaceutical Ltd IPO Listing Date
| BSE Script | |
| NSE Symbol | |
| Listing In | BSE - SME |
| ISIN | INE1CLW01015 |
| IPO Price | ₹- |
| Face Value | ₹- |
Company Contact Information
103 F-1 Leela Apartment ShilpaHSG Society Shanidham Narendra,Nagpur-440015
Phone: +91 712 278 6666
Email: info@goldlinepharma.in
Website: www.goldlinepharma.in
Goldline Pharmaceutical Ltd IPO Registrar
Goldline Pharmaceutical Ltd IPO Lead Manager(s)
- Cumulative Capital Private Limited
How to Check the Allotment Status of Goldline Pharmaceutical Ltd IPO?
To check the IPO allotment status, follow these steps:
- Visit the official website of the IPO registrar.
- Navigate to the IPO Allotment Status page.
- Select “Goldline Pharmaceutical Ltd” from the list of available IPOs.
- Enter any one of these - PAN Number, Application Number, DP/Client ID.
- Click on Submit to view your allotment status.
About Goldline Pharmaceutical Ltd IPO
Goldline Pharmaceutical Limited was originally incorporated on August 2, 2004, as a private limited Company in the name of Goldline Pharmaceutical Private Limited' with the Registrar of Companies, Mumbai. Subsequently, Company was converted into a public limited Company and the name of Company was changed to Goldline Pharmaceutical Limited' w.e.f. September 23, 2013.
IPOs for Subscription
IPOs Articles
Q-Line Biotech Ltd IPO Day 3 Subscription Status
May 25, 2026 | 3 mins read
Q-Line Biotech Ltd is launching its IPO on 21 May 26. Check here the Day 3 IPO subscription status on m.Stock.
Bio Medica Laboratories Ltd IPO Day 3 Subscription Status
May 25, 2026 | 3 mins read
Bio Medica Laboratories Ltd is launching its IPO on 21 May 26. Check here the Day 3 IPO subscription status on m.Stock.